Annual Cash & Cash Equivalents
$1.05 M
-$9.33 M-89.87%
December 1, 2023
Summary
- As of February 22, 2025, BPTH annual cash & cash equivalents is $1.05 million, with the most recent change of -$9.33 million (-89.87%) on December 1, 2023.
- During the last 3 years, BPTH annual cash & cash equivalents has fallen by -$12.70 million (-92.35%).
- BPTH annual cash & cash equivalents is now -95.57% below its all-time high of $23.77 million, reached on December 31, 2021.
Performance
BPTH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$562.00 K
-$3.44 M-85.97%
September 1, 2024
Summary
- As of February 22, 2025, BPTH quarterly cash and cash equivalents is $562.00 thousand, with the most recent change of -$3.44 million (-85.97%) on September 1, 2024.
- Over the past year, BPTH quarterly cash and cash equivalents has dropped by -$1.79 million (-76.11%).
- BPTH quarterly cash and cash equivalents is now -98.17% below its all-time high of $30.79 million, reached on March 31, 2021.
Performance
BPTH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BPTH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -89.9% | -76.1% |
| 3 y3 years | -92.3% | -94.6% |
| 5 y5 years | +4.8% | -94.6% |
BPTH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.6% | at low | -97.6% | +198.9% |
| 5 y | 5-year | -95.6% | at low | -98.2% | +198.9% |
| alltime | all time | -95.6% | >+9999.0% | -98.2% | >+9999.0% |
Bio-Path Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $562.00 K(-86.0%) |
| Jun 2024 | - | $4.01 M(+2030.9%) |
| Mar 2024 | - | $188.00 K(-82.1%) |
| Dec 2023 | $1.05 M(-89.9%) | $1.05 M(-55.3%) |
| Sep 2023 | - | $2.35 M(-31.7%) |
| Jun 2023 | - | $3.44 M(-48.8%) |
| Mar 2023 | - | $6.73 M(-35.2%) |
| Dec 2022 | $10.38 M(-56.3%) | $10.38 M(-23.9%) |
| Sep 2022 | - | $13.65 M(-19.8%) |
| Jun 2022 | - | $17.02 M(-19.9%) |
| Mar 2022 | - | $21.25 M(-10.6%) |
| Dec 2021 | $23.77 M(+72.8%) | $23.77 M(-10.6%) |
| Sep 2021 | - | $26.60 M(-5.3%) |
| Jun 2021 | - | $28.09 M(-8.8%) |
| Mar 2021 | - | $30.79 M(+123.9%) |
| Dec 2020 | $13.76 M(-32.7%) | $13.76 M(+14.1%) |
| Sep 2020 | - | $12.06 M(-16.3%) |
| Jun 2020 | - | $14.41 M(-19.5%) |
| Mar 2020 | - | $17.89 M(-12.4%) |
| Dec 2019 | $20.43 M(+1934.5%) | $20.43 M(+32.8%) |
| Sep 2019 | - | $15.38 M(-10.1%) |
| Jun 2019 | - | $17.11 M(-11.3%) |
| Mar 2019 | - | $19.28 M(+1819.9%) |
| Dec 2018 | $1.00 M(-83.2%) | $1.00 M(-56.1%) |
| Sep 2018 | - | $2.29 M(-11.3%) |
| Jun 2018 | - | $2.58 M(-39.8%) |
| Mar 2018 | - | $4.28 M(-28.2%) |
| Dec 2017 | $5.96 M(-36.4%) | $5.96 M(+29.0%) |
| Sep 2017 | - | $4.62 M(-25.2%) |
| Jun 2017 | - | $6.18 M(-13.1%) |
| Mar 2017 | - | $7.11 M(-24.1%) |
| Dec 2016 | $9.38 M(+5.9%) | $9.38 M(-17.0%) |
| Sep 2016 | - | $11.30 M(+167.5%) |
| Jun 2016 | - | $4.22 M(-34.7%) |
| Mar 2016 | - | $6.47 M(-26.9%) |
| Dec 2015 | $8.85 M(-36.1%) | $8.85 M(-10.2%) |
| Sep 2015 | - | $9.85 M(-11.1%) |
| Jun 2015 | - | $11.08 M(-11.0%) |
| Mar 2015 | - | $12.45 M(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $13.86 M(+290.2%) | $13.86 M(-5.3%) |
| Sep 2014 | - | $14.64 M(-6.9%) |
| Jun 2014 | - | $15.72 M(-6.5%) |
| Mar 2014 | - | $16.82 M(+373.6%) |
| Dec 2013 | $3.55 M(+565.1%) | $3.55 M(-13.4%) |
| Sep 2013 | - | $4.10 M(+112.8%) |
| Jun 2013 | - | $1.93 M(+567.5%) |
| Mar 2013 | - | $288.70 K(-45.9%) |
| Dec 2012 | $534.00 K(-43.9%) | $534.00 K(+60.4%) |
| Sep 2012 | - | $332.90 K(+105.0%) |
| Jun 2012 | - | $162.40 K(-71.8%) |
| Mar 2012 | - | $576.80 K(-39.4%) |
| Dec 2011 | $952.30 K(+299.1%) | $952.30 K(-3.2%) |
| Sep 2011 | - | $983.30 K(-19.5%) |
| Jun 2011 | - | $1.22 M(+59.5%) |
| Mar 2011 | - | $765.80 K(+221.0%) |
| Dec 2010 | $238.60 K(-57.9%) | $238.60 K(+125.9%) |
| Sep 2010 | - | $105.60 K(-82.5%) |
| Jun 2010 | - | $602.40 K(+32.5%) |
| Mar 2010 | - | $454.60 K(-19.9%) |
| Dec 2009 | $567.20 K(-62.4%) | $567.20 K(+113.2%) |
| Sep 2009 | - | $266.00 K(-48.4%) |
| Jun 2009 | - | $515.70 K(-34.2%) |
| Mar 2009 | - | $783.20 K(-48.0%) |
| Dec 2008 | $1.51 M(+4480.9%) | $1.51 M(-15.1%) |
| Sep 2008 | - | $1.78 M(-21.2%) |
| Jun 2008 | - | $2.25 M(-10.1%) |
| Mar 2008 | - | $2.51 M(>+9900.0%) |
| Dec 2007 | - | $17.50 K(+44.6%) |
| Sep 2007 | - | $12.10 K(-63.2%) |
| Jun 2007 | $32.90 K(+242.7%) | $32.90 K(-38.7%) |
| Mar 2007 | - | $53.70 K(+459.4%) |
| Dec 2006 | - | $9600.00(+84.6%) |
| Sep 2006 | - | $5200.00(-45.8%) |
| Jun 2006 | $9600.00(+88.2%) | $9600.00(-36.0%) |
| Mar 2006 | - | $15.00 K(+28.2%) |
| Dec 2005 | - | $11.70 K(-62.4%) |
| Sep 2005 | - | $31.10 K(+509.8%) |
| Jun 2005 | $5100.00(-57.1%) | $5100.00 |
| Jun 2004 | $11.90 K | - |
FAQ
- What is Bio-Path Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bio-Path Holdings?
- What is Bio-Path Holdings annual cash & cash equivalents year-on-year change?
- What is Bio-Path Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bio-Path Holdings?
- What is Bio-Path Holdings quarterly cash and cash equivalents year-on-year change?
What is Bio-Path Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of BPTH is $1.05 M
What is the all time high annual cash & cash equivalents for Bio-Path Holdings?
Bio-Path Holdings all-time high annual cash & cash equivalents is $23.77 M
What is Bio-Path Holdings annual cash & cash equivalents year-on-year change?
Over the past year, BPTH annual cash & cash equivalents has changed by -$9.33 M (-89.87%)
What is Bio-Path Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BPTH is $562.00 K
What is the all time high quarterly cash and cash equivalents for Bio-Path Holdings?
Bio-Path Holdings all-time high quarterly cash and cash equivalents is $30.79 M
What is Bio-Path Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, BPTH quarterly cash and cash equivalents has changed by -$1.79 M (-76.11%)